We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Genedrive collects £0.76m R&D tax credit

Fri 05 June 2026 12:12 | A A A

No recommendation

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

(Sharecast News) - Genedrive said on Friday that it had received a research and development tax credit refund of about 0.76m from HMRC.

The AIM-traded point-of-care pharmacogenetic testing company said the refund related to the financial years ended 30 June 2024 and 30 June 2025.

At 1100 BST, shares in Genedrive were up 4% at 1.3p.

Reporting by Josh White for Sharecast.com.

See latest RNS on Investegate

    The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.


    More AIM news from ShareCast

    No results were found